
Q&A
Biotech and pharmaceutical companies developing innovative gene and cell therapies no longer need to build an in-house capacity to manufacture these therapies. Ascend offers flexible chemistry, manufacturing, and controls (CMC) services for companies working in gene therapy, with an initial focus on Adeno-associated virus (AAV) vectors.
Programming stem cells to differentiate into desired cell types, faster
Using state-of-the-art machine learning models to create custom-build protein drugs
Mapping the brain-body axis to achieve proper immune balance
Using AI to speed through the last mile of drug discovery